A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples